Abstract: Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
INTRODUCTION
Cancer kills over seven million people worldwide every year [1] . The mortality rate of this disease has not changed much in the past few decades even in developed countries as the United States [2] . Although cancer therapy in the form of surgery or radiotherapy is effective when the disease is early detected, many cancers are still diagnosed when cells from a primary tumor have already metastasized to other parts of the body. The main form of treatment at this point is chemotherapy, which consists of delivering drugs systemically so that they can reach and kill the tumor cells. But most of these drugs cause severe side effects in patients and, therefore, need to be used at suboptimal levels. The low efficacy of chemotherapy in patients with advanced cancers is reflected in the low 5-year survival rates observed in these patients [2] . For example, cancer statistics show that the most commonly diagnosed cancer in the world is lung cancer [1] , that approximately 50% of patients diagnosed with this type of cancer have distant metastasis [2] and that only 3% of these patients manage to survive more than 5 years [2] . The low efficacy of cancer therapy for the treatment of patients with metastasis makes the development of novel chemotherapeutic agents necessary.
Despite the recent interest by pharmaceutical companies in molecular modeling, combinatorial chemistry and other synthetic chemistry techniques, natural products and medicinal plants continue to be an important source of new drugs. Natural products are not only used as therapeutic agents, but are also a source of lead compounds that have provided the basis for the semisynthesis or total synthesis of new drugs. An analysis of the sources of drugs approved from January *Address correspondence to this author at the Department of Pharmacology, Faculty of Pharmacy, Profesor Garcia Gonzalez 2, 41012 Sevilla, Spain; Tel: + 34 954 55 63 48; Fax: + 34 954 55 60 74; E-mail: mlopezlazaro@us.es 1981 to the middle of October 2008 revealed that 6% of the 1024 new chemical entities were unmodified natural products and that only 37% were drugs not related to natural products [3, 4] . The role these latter in drug discovery is particularly relevant in oncology. It is estimated that over the time frame from around the 1940s to 2006, of the 155 small molecules approved for cancer therapy, only 27% were not related to natural products [3] . The first plant-derived anticancer agents to advance into clinical use were the Vinca alkaloids vinblastine and vincristine. Other important plantderived anticancer compounds include paclitaxel (taxol), the epipodophyllotoxin derivative etoposide, and the camptothecin derivatives topotecan and irinotecan [5] . The mechanism of action of these drugs is considered to consist in the inhibition of microtubule assembly (Vinca alkaloids and paclitaxel), inhibition of DNA topoisomerase II (etoposide) and inhibition of DNA topoisomerase I (campothecin derivatives). Recent evidence suggests that the formation of reactive oxygen species (ROS) may also contribute to the anticancer effects of these drugs [6] [7] [8] . The induction of oxidative stress by pro-oxidant agents is indeed emerging as an attractive anticancer strategy that may be used to target cancer cells selectively [9] [10] [11] [12] [13] . After discussing the role of oxidative stress in cancer and the possible use of pro-oxidant agents in cancer therapy, this article provides an overview of pro-oxidant natural products with anticancer activity and examines their potential as cancer chemotherapeutic agents.
OXIDATIVE STRESS IN CANCER CELLS
Oxidative stress is an imbalance between the generation and elimination of reactive oxygen species in favor of the former, causing excessive oxidative damage to macromolecules, cells and tissues. Reactive oxygen species (ROS) is the collective term used to name oxygen radicals (including hydroxyl radical and superoxide radical) and some other nonradical derivatives of oxygen, such as hydrogen peroxide (H 2 O 2 ). ROS can easily generate free radicals (any species containing one or more unpaired electrons) and/or cause oxidative damage [14] . ROS are generated by all aerobic organisms and their production seems to be needed for signaltransduction pathways that regulate several different physiological processes. Excessive amounts of ROS, however, can start toxic and lethal chain reactions, which oxidize and disable structures that are required for cellular integrity and survival. ROS are generated in multiple compartments and by multiple enzymes within the cell. Important contributions include proteins within the plasma membrane, such as the growing family of NADPH oxidases; lipid metabolism within the peroxisomes; as well as the activity of various cytosolic enzymes such as cyclooxygenases. Although all these sources contribute to the overall ROS production, the vast majority of cellular ROS can be traced back to the mitochondria [15, 16] .
Accumulating evidence indicates that cancer cells generate excessive levels of ROS and have a state of oxidative stress. Many malignant cells produce high levels of ROS in culture. For instance, Szatrowski and Nathan reported that several tumor cell lines, representing a variety of tissue types, constitutively produced large amounts of H 2 O 2 . They observed that the cumulative amount of H 2 O 2 produced after 4 h by these tumor cells was comparable to the amount of H 2 O 2 produced by similar numbers of phorbol ester-triggered neutrophils [17] . The increased production of ROS by cancer cells observed in vitro has also been found in vivo. For example, chronic lymphocytic leukemia cells freshly taken from patients showed increased ROS production compared with normal lymphocytes. This was also observed with Bcell lines from patients with Burkitt's lymphoma associated with Epstein-Barr virus infection and malignant B-cells from patients with hairy cell leukemia (see [18] and references therein). For solid tumors, however, demonstrating increased ROS production in vivo is difficult to achieve owing to methodological inadequacies, so most researchers have studied oxidative damage levels rather than ROS production. Such studies have shown increased levels of oxidative damage (e.g. 8OHdG) in human cancers and in animal cancers induced by a wide range of carcinogens (reviewed in [18] ). Interestingly, the most important carcinogenic agents and behaviors induce oxidative stress, including most chemical carcinogens (e.g. N-nitrosamines, asbestos, arsenic), ultraviolet radiation, cancer-associated viruses or bacteria, inflammation, alcohol, tobacco smoke and obesity. It is also recognized that age is the principal risk factor for most cancers and that oxidative stress may be the most important causal factor in aging (see [19, 20] and references therein).
The increased levels of ROS of cancer cells seem to play a key role in cancer development [12, 18, 21] . ROS such as H 2 O 2 can induce cell malignant transformation, and the malignant phenotype of tumor cells can be reversed by decreasing the levels of ROS [12, [22] [23] [24] . For instance, expression of the ROS generation system Nox1 in normal NIH3T3 fibroblasts resulted in cells with malignant characteristics that produced tumors in athymic mice. These transformed cells showed a 10-fold increase in H 2 O 2 levels. When human catalase was expressed in these transformed cells, H 2 O 2 concentration decreased, and the cells reverted to a normal appearance, the growth rate normalized, and cells no longer produced tumors in athymic mice [24] . In addition, ROS have been shown to participate in the most relevant aspects of carcinogenesis. Most researchers consider that cancer is a genetic disease caused by the acquisition of multiple mutations in genes that control cell proliferation, cell death and genomic instability [25] . It is also accepted that cells must develop several acquired capabilities in order to become a malignant cancer: increased cell proliferation (caused, in part, by resistance to growth inhibition and independence from mitogenic stimulation), apoptosis resistance, cellular immortalization, increased angiogenesis, invasion and metastasis. In addition, genetic instability is considered to be a key event that enables the acquisition of these capabilities [26, 27] . Accumulating experimental data indicate that an increase in the cellular concentrations of ROS such as H 2 O 2 can explain all these hallmarks of cancer. It is known that an increase in the levels of H 2 O 2 can lead to DNA damage, mutations, and genetic instability [26] [27] [28] [29] [30] [31] ; H 2 O 2 -induced DNA damage seems to be mediated by hydroxyl radical generated from H 2 O 2 by the Fenton reaction [28] [29] [30] . Several studies have also demonstrated that ROS can induce cell proliferation [31] , apoptosis resistance [32, 33] , increased angiogenesis [34, 35] , and invasion and metastasis [36] [37] [38] . Indeed, these studies showed that an increase in the levels of H 2 O 2 -detoxifying enzymes could reduce cell proliferation, promote apoptosis, and inhibit invasion, metastasis and angiogenesis. In short, cancer cells produce high levels of ROS that lead to a state of increased basal oxidative stress. Such state of oxidative stress is induced by the most important human carcinogens and plays an important role in cancer development.
SELECTIVE ANTICANCER ACTIVITY OF PRO-OXIDANT AGENTS
Since cancer cells have increased levels of ROS that play an important role in carcinogenesis, agents with antioxidant activity may induce cancer preventive effects by reducing and/or preventing such increase in the cellular levels of ROS. Because pro-oxidant agents increase the cellular levels of ROS, it is recognized that these agents can induce carcinogenic effects. But when pro-oxidant agents increase the cellular levels of ROS to cytotoxic levels, these agents may induce selective killing of cancer cells and be therapeutically useful. It is important to mention that all these effects can be achieved by agents with both antioxidant and pro-oxidant properties (e.g. curcumin), which can act as cancer chemopreventive, carcinogenic, and chemotherapeutic agents mainly depending on the concentration by which they are used [12, 39] .
The role of ROS in cancer therapy is increasingly being acknowledged and the induction of oxidative stress by prooxidant agents is emerging as an attractive anticancer strategy [9] [10] [11] [12] [40] [41] [42] [43] . Recent data suggests that ROS participate in the anticancer activity of many chemotherapeutic agents commonly used in the clinic, including paclitaxel, docetaxel, cisplatin, doxorubicin, arsenic trioxide, bortezomib, procarbazine and etoposide [6-8, 10, 40, 44-54] . For instance, although it has been known for many years that the microtubule protein tubulin is the therapeutic target for paclitaxel (taxol), recent experiments have shown that the accumulation of H 2 O 2 is a crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo [6, 8] . H 2 O 2 seems to be a key player in oxidative stress-induced cancer cell death. Many anticancer agents increase the levels of H 2 O 2 [6, 45, 47] , and H 2 O 2 is known to be an efficient inducer of cell death in cancer cells [12, 48, 55] . Interestingly, cancer cells are more susceptible to H 2 O 2 -induced cell death than nonmalignant cells [56] [57] [58] . Using several cancer and normal cell lines, Chen et al. [56] [17, 18, 31, [60] [61] [62] . This, and the fact that there is a threshold of H 2 O 2 above which cells cannot survive, may explain why specific concentrations of H 2 O 2 induce selective killing of cancer cells [12] . Excessive cellular accumulation of H 2 O 2 may cause cell death through the induction of DNA damage, which seems to be mediated by hydroxyl radical generated from H 2 O 2 in the presence of iron or copper (Fenton reaction) [28] [29] [30] . Unlike non-malignant cells, cancer cells have mutations in DNA repair genes and cannot properly repair specific types of DNA damage [25, 63] . It is possible that some cancers may have a reduced capacity to repair ROSinduced DNA damage and be more vulnerable than normal cells to the cytotoxic activity of ROS. It has also been proposed that the increased levels of copper found in various malignancies may explain why some pro-oxidant agents (e.g. plant polyphenols) can induce selective killing of cancer cells [64] . The increased levels of copper of cancer cells would favor the formation of higher levels of hydroxyl radical through the Fenton reaction.
PRO-OXIDANT NATURAL PRODUCTS WITH ANTICANCER ACTIVITY
An overview of natural products with both pro-oxidant and anticancer activities is presented in Table 1 . The name of the natural product, the type of compound, the natural source (representative species) and the references are provided. The first part of the table comprises plant compounds of primary metabolism and their derivatives. Then, plant secondary metabolites, including phenolic compounds, terpenoids and alkaloids, are compiled. The last section includes other natural products from different natural sources (compounds of animal, microorganism, or marine origin, vitamins, etc). The mechanism involved in the generation of ROS is not available for most compounds and is not included. The general mechanisms involved in ROS generation by a variety of prooxidant agents (from natural and synthetic origin) have been discussed extensively elsewhere [42] .
Some natural products reported in Fig. (1) and Fig. (2) . The anticancer activity of most compounds compiled in Table 1 has only been evaluated in pre-clinical models.
It is important to mention that, although the pro-oxidant effect of a specific natural product may not be the most important cytotoxic mechanism of action, this pro-oxidant effect may be responsible for the selective anticancer activity of the compound. For instance, it is known that the main mechanism of action of paclitaxel consists in the inhibition of microtubule assembly. A drug that only inhibits microtubule assembly would be equally cytotoxic in cells with the same proliferating rate, as microtubules are necessary for cell proliferation. Because it is known that cancer cells are more vulnerable to paclitaxel than highly proliferating nonmalignant cells, it has been enigmatic for many years why this drug has certain selectivity for cancer cells [25] . Recently, it was observed that the accumulation of H 2 O 2 is crucial for paclitaxel-induced cancer cell death both in vitro and in vivo [6, 8] . Being well known that H 2 O 2 can induce selective killing of cancer cells, it seems possible that paclitaxelinduced H 2 O 2 production plays a role in the selective anticancer effects of this natural product.
Since the redox state of the cell is important for many cellular processes, it has been discussed that pro-oxidant agents may act as "dirty" drugs (agents that modulate multiple molecular targets through pleiotropic interactions). However, recent research suggests that this pleiotropic mode of action may be an advantage to overcome cancer cell drug resistance typical of drugs acting on just one target [42] . Although pro-oxidant agents could be used as stand-alone drugs, evidence suggests that they could also be used in combination [42] . Indeed, although ROS induce cancer cell death, tumor cells are known to develop mechanisms that prevent ROS from reaching cytotoxic levels. The glutathione and thioredoxin antioxidant systems are crucial for detoxifying ROS. These antioxidant systems are activated in cancer cells and play an important role in the development of resistance to many anticancer agents [65] [66] [67] [68] [69] [70] [71] . The possible drug resistance induced by pro-oxidant agents could be reduced with glycolysis inhibitors [13] . Evidence indicates that prooxidant agents can increase the cellular levels of H 2 O 2 and that glycolysis inhibitors can reduce the capacity of cells to detoxify H 2 O 2 . Experimental data have shown that malignant cells are more susceptible to glucose deprivation than nontransformed cells, and that an increase in the levels of H 2 O 2 may mediate the cytotoxic effect induced by glucose deprivation [62, [72] [73] [74] . Two possible mechanisms may explain why the activation of glycolysis plays an important function in protecting tumor cells from H 2 O 2 -induced cell death. First, the activation of glycolysis increases the formation of pyru- Gentiacaulein Xanthone Gentiana kochiana (Gentianaceae) [187] Gentiakochianin Xanthone Gentiana kochiana (Gentianaceae) [187] Guttiferone-A Benzophenone Garcinia livingstonei (Clusiaceae) [188] Hesperetin Flavanone Citrus spp. (Rutaceae) [189, 190] Hydroxytyrosol Simple Phenol Olea europaea (Oleaceae) [191] Icariin Flavonol glycoside Epimedium spp. (Berberidaceae) [192] Isoeugenol Phenylpropanoid Eugenia caryophyllata (Myrtaceae) [193, 194] Isoliquiritigenin Chalcone Glycyrrhiza glabra (Fabaceae) [178, 195] Juglone Naphtoquinone Juglans regia (Juglandaceae) [196, 197] Kaempferol Flavonol Kaempferia galanga (Zingiberaceae), widespread [198, 199] Liquiritigenin Flavanone Glycyrrhiza glabra (Fabaceae) [200] Luteolin Flavone Reseda luteola (Resedaceae), widespread [201, 202] Malvidin Anthocyanidin Althaea rosea (Malvaceae) [157, 203] Malvidin Ginkgolide B Diterpenoid Ginkgo biloba (Ginkgoaceae) [284, 285] Ginsenoside RH-2 Triterpenoid saponin Ginkgo biloba (Ginkgoaceae) [286, 287] Glaucocalyxin A Diterpenoid Rabdosia japonica var. glaucocalyx (Lamiaceae) [288] Guggulsterone Triterpenoid Commiphora mukul (Burseraceae) [289, 290] Gypenosides Triterpenoid Gynostemma pentaphyllum (Cucurbitaceae) [291, 292] Helenalin Sesquiterpenoid Arnica spp. (Asteraceae) [293] Linalool Monoterpenoid Coriandrum sativum (Apiaceae), widespread [294] ( [345] [346] [347] Camptothecin Quinoline Camptotheca acuminata (Nyssaceae) [7, 348] Cepharanthine Isoquinoline Stephania cepharantha (Menispermaceae) [349, 350] ( vate, which is an efficient scavenger of H 2 O 2 [75] [76] [77] [78] . Second, glucose metabolism through the pentose phosphate pathway regenerates NADPH from NADP + in a reaction in which glucose-6-phosphate is converted into 6-phosphogluconolactone by the enzyme glucose-6-phosphate dehydrogenase. The regeneration of NADPH is required for H 2 O 2 detoxification through the glutathione peroxidase/glutathione reductase system and through the thioredoxin peroxidase/thioredoxin reductase system [73, 79, 80] (reviewed in [13] ). Therefore, the anticancer potential of prooxidant natural products could be maximized in combination with glycolysis inhibitors.
In conclusion, natural products have made a significant contribution to the development of many anticancer drugs currently used in chemotherapy. Recent observations suggest that pro-oxidant agents may represent a new class of anticancer drugs with capacity to target tumor cells selectively. In this article, we have provided an overview of pro-oxidant natural products with anticancer activity and discussed their anticancer potential.
